Publications by authors named "Christine Mack"

Claim this Profile
I
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids.
James L Trevaskis, Christine M Mack, Chengzao Sun, Christopher J Soares, Lawrence J D'Souza

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists.
David A Griffith, Diane M Hargrove, Tristan S Maurer, Charles A Blum, Stéphane De Lombaert, Christine M Mack

Bioorg Med Chem Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats.
James L Trevaskis, Victoria F Turek, Carrie Wittmer, Peter S Griffin, Julie K Wilson, Christine M Mack

Endocrinology· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Jonathan D Roth, Todd Coffey, Carolyn M Jodka, Holly Maier, Jennifer R Athanacio, Christine M Mack

Endocrinology· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.
Christine Mack, Julie Wilson, Jennifer Athanacio, James Reynolds, Kevin Laugero

Am J Physiol Regul Integr Comp Physiol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.
Sean H Adams, Chunli Lei, Carolyn M Jodka, Svetlana E Nikoulina, Julie A Hoyt, Christine M Mack

J Nutr· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists.
Richard L Elliott, Robert M Oliver, Janet A LaFlamme, Melissa L Gillaspy, Marlys Hammond, Christine M Mack

Bioorg Med Chem Lett· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships in a series of NPY Y5 antagonists: 3-amido-9-ethylcarbazoles, core-modified analogues and amide isosteres.
Marlys Hammond, Richard L Elliott, Melissa L Gillaspy, David C Hager, Richard F Hank, Christine M Mack

Bioorg Med Chem Lett· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist.
Richard L Elliott, Robert M Oliver, Marlys Hammond, Terrell A Patterson, Li She, Christine M Mack

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis